Qinghai Spring Medicinal Resources Technology Co., Ltd. Stock price
Equities
600381
CNE0000017W0
Pharmaceuticals
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
5.03 CNY | +0.80% | -12.67% | -34.93% |
Sales 2021 | 128M 17.69M | Sales 2022 | 160M 22.18M | Capitalization | 7.23B 1B |
---|---|---|---|---|---|
Net income 2021 | -249M -34.48M | Net income 2022 | -288M -39.89M | EV / Sales 2021 | 37.2 x |
Net cash position 2021 | 198M 27.49M | Net cash position 2022 | 164M 22.78M | EV / Sales 2022 | 44.1 x |
P/E ratio 2021 |
-20.1
x | P/E ratio 2022 |
-25.1
x | Employees | 175 |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 55.91% |
1 day | +0.80% | ||
1 week | -12.67% | ||
Current month | -14.89% | ||
1 month | -11.75% | ||
3 months | -34.76% | ||
6 months | -36.89% | ||
Current year | -34.93% |
Managers | Title | Age | Since |
---|---|---|---|
Xue Feng Zhang
CEO | Chief Executive Officer | 55 | 15-10-29 |
Lin Wang
DFI | Director of Finance/CFO | 55 | 18-05-17 |
Tie Peng Yao
BRD | Director/Board Member | 71 | 15-05-14 |
Members of the board | Title | Age | Since |
---|---|---|---|
Xue Min Gao
BRD | Director/Board Member | 86 | 20-06-03 |
Rong Xiao
BRD | Director/Board Member | 54 | - |
Xue Feng Zhang
CEO | Chief Executive Officer | 55 | 15-10-29 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.00% | 36 M€ | +4.92% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-03-28 | 5.03 | +0.80% | 17,081,530 |
24-03-27 | 4.99 | -5.67% | 21,688,080 |
24-03-26 | 5.29 | +2.12% | 22,219,560 |
24-03-25 | 5.18 | -5.82% | 28,941,580 |
24-03-22 | 5.5 | -4.51% | 40,202,440 |
End-of-day quote Shanghai S.E., March 27, 2024
More quotesAnnual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-34.93% | 409M | |
+23.32% | 5.42B | |
-12.48% | 4.67B | |
-6.70% | 3.27B | |
-16.43% | 2.62B | |
-2.41% | 2.54B | |
-7.97% | 1.68B | |
+24.37% | 1.66B | |
-8.02% | 1.62B | |
-4.40% | 1.58B |